Clinical Trial Update: A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population [Phase 3]

View source ↗

Summary

Phase 3 study evaluating pharmacodynamic effects of four weeks of omeprazole treatment in Japanese patients with non-erosive reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Reflux Disease

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Non-erosive Reflux Disease | Phase 3 | Status: COMPLETED